Skip to main navigation Skip to search Skip to main content

Metabolic and paracrine heterogeneity of pancreatic glucagon-secreting α-cells

  • Haiqiang Dou
  • , Caroline Miranda
  • , Johan Tolö
  • , Cristiano Santos
  • , Rui Gao
  • , Nikhil R. Gandasi
  • , Thomas G. Hill
  • , Lakshmi Kothegala
  • , Andrei I. Tarasov
  • , Quan Zhang
  • , Patrik Rorsman

Research output: Contribution to journalArticlepeer-review

4 Downloads (Pure)

Abstract

By stimulating hepatic glucose production, glucagon (released by islet α-cells) restores normal blood glucose levels when they fall below the normal range. We used optogenetics in conjunction with electrophysiology, cytoplasmic free Ca2+ concentration imaging, and hormone release measurements to explore the intrinsic and paracrine regulation of glucagon secretion. Many α-cells were spontaneously active at 1 mmol/L glucose. However, up to ∼50% of the α-cells were electrically silent. KATP channel blockade, amino acids, and somatostatin receptor antagonism restored electrical activity in such α-cells. Termination of optoactivation resulted in KATP channel–dependent (tolbutamide sensitive) membrane repolarization in active α-cells but long-lasting membrane depolarization and action potential firing in silent α-cells. The latter effect was associated with an increased cytoplasmic ATP:ADP ratio. Optoactivation or optoinhibition of somatostatin-releasing δ-cells inhibits and stimulates electrical activity in adjacent (but not distal) α-cells. There is an inverse relationship between basal glucagon secretion (a measure of the fraction active α-cells) and the relative stimulatory effects of amino acids. We conclude that islet α-cells are functionally heterogenous and that their electrical excitability and glucagon release are determined by K+ channel activity due to variable mosaic of KATP and somatostatin-sensitive K+ channels reflecting metabolic state and proximity to δ-cells, respectively.
Original languageEnglish
Pages (from-to)2307-2321
Number of pages15
JournalDiabetes
Volume74
Issue number12
Early online date4 Apr 2025
DOIs
Publication statusPublished (in print/issue) - 30 Dec 2025

Bibliographical note

© 2025 by the American Diabetes Association.

Funding

C.M. holds a postdoctoral fellowship from the Swedish Society for Medical Research. Q.Z. held a Diabetes UK RD Lawrence Fellowship during the initial stages of the project. This work was supported by Research Council UK, Medical Research Council (MR/VO11979/1), The Leona M. and Harry B. Helmsley Charitable Trust (G-1912-03553 and G-2305-06047), Swedish Research Council (2013-7107), and Diabetes Research and Wellness Sweden (DWS-2023-0042 PG).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Glucagon-Secreting Cells/metabolism
  • Animals
  • Glucagon/metabolism
  • Paracrine Communication/physiology
  • KATP Channels/metabolism
  • Mice
  • Somatostatin/metabolism
  • Action Potentials/drug effects
  • Glucose/metabolism
  • Amino Acids/pharmacology

Fingerprint

Dive into the research topics of 'Metabolic and paracrine heterogeneity of pancreatic glucagon-secreting α-cells'. Together they form a unique fingerprint.

Cite this